col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


71 Results       Page 1

 [1] 
BMJ: Journal for ImmunoTherapy of Cancer
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2024―Jan―31 Effects of antineoplastic and immunomodulating agents on postvaccination SARS-CoV-2 breakthrough infections, antibody response, and serological cytokine profile Jacob New, Jason Cham, Lana Smith, Leah Puglisi, Tridu Huynh, Sunil Kurian, Samantha Bagsic, Russel Fielding, Lee Hong, Priya Reddy, Ki Suk Eum, Allison Martin, Bethany Barrick, Christopher Marsh, Michael Quigley, Laura J Nicholson, Amitabh C Pandey
2 [GO] 2024―Jan―10 mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer No-Joon Song, Karthik B Chakravarthy, Hyeongseon Jeon, Chelsea Bolyard, Kelsi Reynolds, Kevin P Weller, Sarah Reisinger, Yi Wang, Anqi Li, Sizun Jiang, Qin Ma, Dan H Barouch, Mark P Rubinstein, Peter G Shields, Eugene M Oltz, Dongjun Chung, Zihai Li
3 [GO] 2023―Apr―28 Correction: JAK inhibitors and COVID-19
4 [GO] 2023―Feb―06 COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis Juan Ignacio Ruiz, Maria Angeles Lopez-Olivo, Yimin Geng, Maria E Suarez-Almazor
5 [GO] 2023―Jan―27 SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report Kevin Owen McNerney, Rebecca M Richards, Paibel Aguayo-Hiraldo, Friso G Calkoen, Julie-An Talano, Amy Moskop, Adriana Balduzzi, Jennifer Krajewski, Hema Dave, Anant Vatsayan, Colleen Callahan, Hongyan Liu, Yimei Li, Kara Lynn Davis, Shannon L Maude
6 [GO] 2022―Nov―30 Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries Alessio Cortellini, Gino M Dettorre, Urania Dafni, Juan Aguilar-Company, Luis Castelo-Branco, Matteo Lambertini, Spyridon Gennatas, Vasileios Angelis, Ailsa Sita-Lumsden, Jacobo Rogado, Paolo Pedrazzoli, David Viñal, Aleix Prat, Maura Rossi, Rossana Berardi, Teresa Alonso-Gordoa, Salvatore Grisanti, Georgia Dimopoulou, Paola Queirolo, Sylvain Pradervand, Alexia Bertuzzi, Mark Bower, Dirk Arnold, Ramon Salazar, Marco Tucci, Kevin J Harrington, Francesca Mazzoni, Uma Mukherjee, Zoi Tsourti, Olivier Michielin, Fanny Pommeret, Joan Brunet, Bruno Vincenzi, Giuseppe Tonini, Andrea Patriarca, Federica Biello, Marco Krengli, Josep Tabernero, George Pentheroudakis, Alessandra Gennari, Solange Peters, Emanuela Romano, David J Pinato
7 [GO] 2022―Nov―08 Correction: On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19
8 [GO] 2022―Jul―18 T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine Djordje Atanackovic, Robert J Kreitman, Jeffrey Cohen, Nancy M Hardy, Destiny Omili, Thierry Iraguha, Peter D Burbelo, Etse Gebru, Xiaoxuan Fan, John Baddley, Tim Luetkens, Saurabh Dahiya, Aaron P Rapoport
9 [GO] 2022―Jun―22 Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies Sherin Juliet Rouhani, Jovian Yu, Daniel Olson, Yuanyuan Zha, Apameh Pezeshk, Alexandra Cabanov, Athalia R Pyzer, Jonathan Trujillo, Benjamin A Derman, Peter O'Donnell, Andrzej Jakubowiak, Hedy L Kindler, Christine Bestvina, Thomas F Gajewski
10 [GO] 2022―Apr―28 JAK inhibitors and COVID-19 Gabriel Levy, Paola Guglielmelli, Peter Langmuir, Stefan Constantinescu
11 [GO] 2022―Mar―10 Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
12 [GO] 2022―Mar―09 Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world study Qi Mei, Guangyuan Hu, Yang Yang, Bo Liu, Junping Yin, Ming Li, Qiao Huang, Xi Tang, Alexander Böhner, Amy Bryant, Christian Kurts, Xianglin Yuan, Jian Li
13 [GO] 2022―Mar―03 Spontaneous tumor regression following COVID-19 vaccination Luana Guimaraes de Sousa, Daniel J McGrail, Kaiyi Li, Mario L Marques-Piubelli, Cipriano Gonzalez, Hui Dai, Sammy Ferri-Borgogno, Myrna Godoy, Jared Burks, Shiaw-Yih Lin, Diana Bell, Renata Ferrarotto
14 [GO] 2021―Nov―29 Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis Yifei Ma, Nianqi Liu, Youlong Wang, Jiling Zeng, Ying-Ying Hu, Wu Hao, Huazheng Shi, Pengfei Zhu, Jun Lv, Wei Fan, Xinjia Wang
15 [GO] 2021―Nov―09 701 Activating CD73 on B cells as a target for immunotherapy of COVID-19 and viral associated cancers: clinical activity in human papilloma virus positive (HPV) head and neck squamous cell cancers (HNSCC) Jason Luke, Jaime Merchan, Brett Hughes, Jeffrey Sosman, Abhishek Tripathi, Igor Puzanov, Thomas Marron, Kristen Marrone, Craig Hill, James Janc, Jenny Rudnick, Shenshen Hu, Mehrdad Mobasher, Suresh Mahabhashyam, Richard Miller
16 [GO] 2021―Nov―09 626 Dissecting the spatial heterogeneity of SARS-CoV-2-infected tumour microenvironment reveals a lymphocyte-dominant immune response in a HBV-associated HCC patient with COVID-19 history Benedict Tan, Yi Yang, Chun Chau Lawrence Cheung, Denise Goh, Mai Chan Lau, Xinru Lim, Jeffrey Lim, Li Wen Justina Nadia Lee, Tracy Tien, Shirin Kalimuddin, Wai Meng David Tai, Jenny Low, Cedric Chuan Young Ng, Wei Qiang Leow, Thuan Tong Tan, Tony Lim, Jin Liu, Joe Yeong
17 [GO] 2021―Nov―09 625 COVID-19 vaccination in patients with renal cancer or melanoma receiving immune checkpoint inhibitors Joyce Hwang, Hannah Dzimitrowicz, Riddhishkumar Shah, Kathleen Ashcraft, Daniel George, April Salama, Tian Zhang
18 [GO] 2021―Nov―09 896 Fighting the war against COVID-19: administration of bamlanivimab (BAM) or bamlanivimab + etesivimab (BAM + E); a cooperative effort between a community cancer center and an urgent care (UC) facility Patrick Skeffington, Robert Aisenberg, Janice Dallacosta, Ian Donaghy, Dani Hackner, Kelly Houde, Kathy Moraes, Annemarie Santos
19 [GO] 2021―Oct―13 Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
20 [GO] 2021―Oct―13 Correction: SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study
21 [GO] 2021―Aug―05 Correction: COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report
22 [GO] 2021―Jul―16 Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors Benjamin Switzer, John Haanen, Paul C Lorigan, Igor Puzanov, Samra Turajlic
23 [GO] 2021―Jun―16 Correction: Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
24 [GO] 2021―Jun―11 COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies Jason D Goldman, Philip C Robinson, Thomas S Uldrick, Per Ljungman
25 [GO] 2021―Jun―11 Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients Emanuela Romano, Steve Pascolo, Patrick Ott
26 [GO] 2021―May―13 Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy Lorenzo Iovino, Laurel A Thur, Sacha Gnjatic, Aude Chapuis, Filippo Milano, Joshua A Hill
27 [GO] 2021―May―07 Immune profiling of COVID-19: preliminary findings and implications for the pandemic Holden T Maecker
28 [GO] 2021―Apr―30 Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations Muhammad Bilal Abid
29 [GO] 2021―Apr―09 IL-6 modulation for COVID-19: the right patients at the right time? Paolo Antonio Ascierto, Binqing Fu, Haiming Wei
30 [GO] 2021―Mar―22 Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score Gino M Dettorre, Saoirse Dolly, Angela Loizidou, John Chester, Amanda Jackson, Uma Mukherjee, Alberto Zambelli, Juan Aguilar-Company, Mark Bower, Christopher C T Sng, Ramon Salazar, Alexia Bertuzzi, Joan Brunet, Ricard Mesia, Ailsa Sita-Lumsden, Elia Seguí, Federica Biello, Daniele Generali, Salvatore Grisanti, Pavetha Seeva, Gianpiero Rizzo, Michela Libertini, Antonio Maconi, Charlotte Moss, Beth Russell, Nadia Harbeck, Bruno Vincenzi, Rossella Bertulli, Diego Ottaviani, Raquel Liñan, Andrea Marrari, M Carmen Carmona-García, Neha Chopra, Carlo Alberto Tondini, Oriol Mirallas, Valeria Tovazzi, Vittoria Fotia, Claudia Andrea Cruz, Nadia Saoudi-Gonzalez, Eudald Felip, Ariadna Roqué, Alvin J X Lee, Tom Newsom-Davis, David García-Illescas, Roxana Reyes, Yien Ning Sophia Wong, Daniela Ferrante, Lorenza Scotti, Javier Marco-Hernández, Isabel Ruiz-Camps, Andrea Patriarca, Lorenza Rimassa, Lorenzo Chiudinelli, Michela Franchi, Armando Santoro, Aleix Prat, Alessandra Gennari, Mieke Van Hemelrijck, Josep Tabernero, Nikolaos Diamantis, David J Pinato
31 [GO] 2021―Mar―18 Severity of COVID-19 in patients with lung cancer: evidence and challenges Antonio Passaro, Christine Bestvina, Maria Velez Velez, Marina Chiara Garassino, Edward Garon, Solange Peters
32 [GO] 2021―Mar―11 Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic Renee N Donahue, Jennifer L Marté, Meghali Goswami, Nicole J Toney, Yo-Ting Tsai, James L Gulley, Jeffrey Schlom
33 [GO] 2021―Mar―09 Perspectives on COVID-19 and cancer immunotherapy: a review series Jason D Goldman, Paolo Antonio Ascierto
34 [GO] 2021―Feb―17 SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study Mario Mandala, Paul Lorigan, Matilde De Luca, Andrea Bianchetti, Barbara Merelli, Anna Cecilia Bettini, Lucia Bonomi, Sharon Nahm, Maria Grazia Vitale, Giorgia Negrini, Andrea Di Croce, Paolo Antonio Ascierto, Eliana Rulli, Carlo Alberto Tondini
35 [GO] 2021―Feb―11 COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report Angelo Dipasquale, Pasquale Persico, Elena Lorenzi, Daoud Rahal, Armando Santoro, Matteo Simonelli
36 [GO] 2021―Jan―19 Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition Aljosja Rogiers, Ines Pires da Silva, Chiara Tentori, Carlo Alberto Tondini, Joseph M Grimes, Megan H Trager, Sharon Nahm, Leyre Zubiri, Michael Manos, Peter Bowling, Arielle Elkrief, Neha Papneja, Maria Grazia Vitale, April A N Rose, Jessica S W Borgers, Severine Roy, Joanna Mangana, Thiago Pimentel Muniz, Tim Cooksley, Jeremy Lupu, Alon Vaisman, Samuel D Saibil, Marcus O Butler, Alexander M Menzies, Matteo S Carlino, Michael Erdmann, Carola Berking, Lisa Zimmer, Dirk Schadendorf, Laura Pala, Paola Queirolo, Christian Posch, Axel Hauschild, Reinhard Dummer, John Haanen, Christian U Blank, Caroline Robert, Ryan J Sullivan, Paolo Antonio Ascierto, Wilson H Miller Jr, F Stephen Hodi, Karijn P M Suijkerbuijk, Kerry L Reynolds, Osama E Rahma, Paul C Lorigan, Richard D Carvajal, Serigne Lo, Mario Mandala, Georgina V Long
37 [GO] 2020―Dec―10 Management of immune checkpoint therapy for patients with cancer in the face of COVID-19 Chen Shen, Qianru Li, Yongchang Wei, Yuting Li, Jun Li, Juan Tao
38 [GO] 2020―Nov―20 Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management Jennifer L Marté, Nicole J Toney, Lisa Cordes, Jeffrey Schlom, Renee N Donahue, James L Gulley
39 [GO] 2020―Nov―09 476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19 Tingting Zhong, Zhaoliang Huang, Xinghua Pang, Na Chen, Konyew Kwek, Chris Wynne, Adam Konpa, Xiaoping Jin, Yu Xia, Maxwell Zhongmin Wang, Baiyong Li, Yu Xia
40 [GO] 2020―Nov―09 659 Blocking cytokine IL-1 with anakinra for the prevention of cytokine release syndrome in COVID-19 Erik Soule, Jason Williams, Matthias Piesche
41 [GO] 2020―Nov―09 482 COVID-19 in patients with lung cancer receiving immunotherapy. A report from an spanish academic center David Viñal, Laura Gutierrez, Julia Villamayor, Oliver Higuera, Dario Sanchez Cabrero, Javier De Castro
42 [GO] 2020―Nov―09 826 Risk of COVID-19 infection among patients receiving immune checkpoint inhibitor therapy: a tertiary care hospital system collaboration with the Massachusetts department of health William Murphy, Vartan Pahalyants, Nikolai Klebanov, Nicholas Theodosakis, Leyre Zubiri, Monina Klevens, Evelyn Lilly, Kerry Reynolds, Yevgeniy Semenov
43 [GO] 2020―Nov―09 483 Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis Olivier Demaria, Julien Carvelli, Nassima Chouaki Benmansour, Joanna Fares, Luciana Batista, Marie-Laure Thibult, Ariane Morel, Sabrina Carpentier, Romain Remark, Agnes Represa, Frederic Vely, Mikael Ebbo, Nicolas Schleinitz, Robert Zerbib, Yannis Morel, Eric Vivier, Olivier Demaria
44 [GO] 2020―Nov―09 481 Impact of COVID-19 on Cancer Patients Receiving Immune Checkpoint Inhibitors Kevin Tyan, Ai-Tram Bui, Anita Giobbie-Hurder, Isaac Klein, Michael Manos, Leyre Zubiri, Kerry Reynolds, Shilpa Grover, Gerald Weinhouse, Patrick Ott, Nicole LeBoeuf, Osama Rahma
45 [GO] 2020―Nov―09 475 Incidental finding of colorectal cancer in a COVID-19 patient, followed by deep profiling of SARS-CoV-2-associated immune landscape and tumour microenvironment Chun Chau Lawrence Cheung, Xinru Lim, Denise Goh, Tracy Zhijun Tien, Jeffrey Chun Tatt Lim, Thuan Tong Tan, Shirin Kalimuddin, Jia Lin Ng, Jenny Guek-Hong Low, Joe Yeong, Kiat Hon Lim
46 [GO] 2020―Nov―09 825 Deep immune profiling of SARS-CoV-2 associated immune microenvironment in cancer tissues from recovered COVID-19 patients Denise Goh, Chun Chau Lawrence Cheung, Xinru Lim, Tracy Zhijun Tien, Jeffrey Chun Tatt Lim, Sanjna Nilesh Nerurkar, Loong Shihleone, Peng Chung Cheow, Chung Yip Chan, Ye Xin Koh, Thuan Tong Tan, Shirin Kalimuddin, Wai Meng David Tai, Jia Lin Ng, Jenny Guek-Hong Low, Joe Poh Sheng Yeong, Tony Kiat Hon Lim
47 [GO] 2020―Nov―09 477 Deep learning to drive COVID-19 rapid drug repurposing Sarah Kolitz, Jason Kim, Jenny Zhang, Yoonjeong Cha, Sailaja Battula, Rebecca Kusko, Rajaraman Krishnan, Benjamin Zeskind, Howard Kaufman
48 [GO] 2020―Nov―09 325 Immunotherapy with B cell activating antibody CPI-006 in patients (pts) with mild to moderate COVID-19 stimulates anti-SARS-CoV-2 antibody response, memory B cells and memory T effector cells Gerard Criner, Mehrdad Mobasher, Craig Hill, Shenshen Hu, Suresh Mahabhashyam, Joshua Brody, Thomas Marron, Stephen Willingham, Richard Miller
49 [GO] 2020―Nov―09 480 Preliminary evaluation of a novel coronavirus vaccine (CORVax) using electroporation of plasmid DNA encoding a stabilized prefusion SARS-CoV-2 spike protein alone or with transfection of plasmid IL-12 Shawn Jensen, Christopher Twitty, Christopher Paustian, Madelein Laws, Glenna McDonnell, Keith Wegmann, Tarsem Moudgil, Michael Afentoulis, Mia Han, Kellie Malloy Foerter, David Canton, Jack Lee, Bianca Nguyen, John Rodriguez, Kim Jaffe, Brian Piening, Carlo Bifulco, Daniel O’Connor, Walter Urba, Rom Leidner, Traci Hilton, Hong-Ming Hu, Bernard Fox
50 [GO] 2020―Nov―09 479 A lymph-node targeted amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2 Martin Steinbuck, Peter DeMuth, Lochana Seenappa, Christopher Haqq, Aniela Jakubowski, Lisa McNeil
51 [GO] 2020―Nov―09 326 SARS-CoV-2 specific T-cells in TIL from patients with epithelial cancer Pedro Noronha, Georgia Paraschoudi, Eric Sousa, Jéssica Kamiki, Patrícia António, Carolina Condenço, Inês Silva, Andreia Maia, Mireia Castillo-Martin, António Beltran, Carlos Carvalho, Joana Lerias, Alimuddin Zumla, Markus Maeurer
52 [GO] 2020―Nov―09 478 Translation of a therapeutic neoantigen vaccine workflow to SARS-CoV-2 vaccine development Christof Smith, Sarah Entwistle, Caryn Willis, Steven Vensko, Wolfgang Beck, Jason Garness, Maria Sambade, Eric Routh, Kelly Olsen, Brandon Carpenter, Kaylee Gentry, Maria Fadri, Misha Fini, Amber Washington, Julia Kodysh, Timothy O’Donnell, Carsten Haber, Kirsten Heiss, Volker Stadler, Erik Garrison, Oliver Grant, Robert Woods, Mark Heise, Benjamin Vincent, Alexander Rubinsteyn
53 [GO] 2020―Nov―09 863 Identification and characterization of an immunodominant SARS-CoV-2-specific CD8 T cell response Anastasia Gangaev, Pia Kvistborg
54 [GO] 2020―Oct―16 Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey Nilasha Ghosh, Aidan Tirpack, Karmela K Chan, Anne R Bass
55 [GO] 2020―Oct―15 Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists Margaret Ottaviano, Marcello Curvietto, Pasquale Rescigno, Marianna Tortora, Giovannella Palmieri, Diana Giannarelli, Michele Aieta, Pasquale Assalone, Laura Attademo, Antonio Avallone, Francesco Bloise, Davide Bosso, Valentina Borzillo, Giuseppe Buono, Giuseppe Calderoni, Francesca Caputo, Giacomo Cartenì, Diletta Cavallero, Alessia Cavo, Fortunato Ciardiello, Raffaele Conca, Vincenza Conteduca, Stefano De Falco, Marco De Felice, Michelino De Laurentiis, Pietro De Placido, Sabino De Placido, Irene De Santo, Alfonso De Stefano, Carminia Maria Della Corte, Rossella Di Franco, Vincenzo Di Lauro, Antonietta Fabbrocini, Piera Federico, Lucia Festino, Pasqualina Giordano, Mario Giuliano, Cesare Gridelli, Antonio Maria Grimaldi, Michela Lia, Antonella Lucia Marretta, Valentina Massa, Alessia Mennitto, Sara Merler, Valeria Merz, Carlo Messina, Marco Messina, Monica Milano, Alessandro Marco Minisini, Vincenzo Montesarchio, Alessandro Morabito, Floriana Morgillo, Brigitta Mucci, Lucia Nappi, Fabiana Napolitano, Immacolata Paciolla, Martina Pagliuca, Giuseppe Palmieri, Sara Parola, Stefano Pepe, Angelica Petrillo, Francovito Piantedosi, Luisa Piccin, Fernanda Picozzi, Erica Pietroluongo, Sandro Pignata, Veronica Prati, Vittorio Riccio, Mario Rosanova, Alice Rossi, Anna Russo, Massimiliano Salati, Giuseppe Santabarbara, Andrea Sbrana, Ester Simeone, Antonia Silvestri, Massimiliano Spada, Paolo Tarantino, Paola Taveggia, Federica Tomei, Tortora Vincenzo, Dario Trapani, Claudia Trojanello, Vito Vanella, Sabrina Vari, Jole Ventriglia, Maria Grazia Vitale, Fabiana Vitiello, Caterina Vivaldi, Claudia von Arx, Francesca Zacchi, Ilaria Zampiva, Andrea Zivi, Bruno Daniele, Paolo Antonio Ascierto
56 [GO] 2020―Sep―07 A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study Chao Liu, Li Li, Kehan Song, Zhi-Ying Zhan, Yi Yao, Hongyun Gong, Yuan Chen, Qun Wang, Xiaorong Dong, Zhibin Xie, Chun-Quan Ou, Qinyong Hu, Qibin Song
57 [GO] 2020―Sep―07 Correction: Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
58 [GO] 2020―Aug―26 Amendment to 'Correction: Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19'
59 [GO] 2020―Aug―11 Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy Vincenzo Montesarchio, Roberto Parella, Chiara Iommelli, Antonella Bianco, Elio Manzillo, Fiorentino Fraganza, Cristiana Palumbo, Gaetano Rea, Patrizia Murino, Rosanna De Rosa, Luigi Atripaldi, Maurizio D’Abbraccio, Marcello Curvietto, Domenico Mallardo, Egidio Celentano, Antonio Maria Grimaldi, Marco Palla, Claudia Trojaniello, Maria Grazia Vitale, Samuel Lewis Million-Weaver, Paolo Antonio Ascierto
60 [GO] 2020―Jul―30 SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity Jia Wei, Jianping Zhao, Meifang Han, Fankai Meng, Jianfeng Zhou
61 [GO] 2020―Jul―22 Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment Ernesto Rossi, Giovanni Schinzari, Giampaolo Tortora
62 [GO] 2020―Jul―16 ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19 Riyue Bao, Kyle Hernandez, Lei Huang, Jason John Luke
63 [GO] 2020―Jul―07 BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy Madhuri Koti, Alvaro Morales, Charles H Graham, David Robert Siemens
64 [GO] 2020―Jul―02 On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19 Thilo Gambichler, Judith Reuther, Christina H Scheel, Jürgen Christian Becker
65 [GO] 2020―Jun―18 Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management Jarushka Naidoo, Joshua E Reuss, Karthik Suresh, David Feller-Kopman, Patrick M Forde, Seema Mehta Steinke, Clare Rock, Douglas B Johnson, Mizuki Nishino, Julie R Brahmer
66 [GO] 2020―May―20 COVID-19 and immune checkpoint inhibitors: initial considerations Ryan J Sullivan, Douglas B Johnson, Brian I Rini, Tomas G Neilan, Christine M Lovly, Javid J Moslehi, Kerry L Reynolds
67 [GO] 2020―May―20 COVID-19 and lung cancer: risks, mechanisms and treatment interactions Alfredo Addeo, Michel Obeid, Alex Friedlaender
68 [GO] 2020―May―20 Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy Michael T Serzan, Princy N Kumar, Michael B Atkins
69 [GO] 2020―May―08 The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response Fernanda I Arnaldez, Steven J O'Day, Charles G Drake, Bernard A Fox, Bingqing Fu, Walter J Urba, Vincenzo Montesarchio, Jeffrey S Weber, Haiming Wei, Jon M Wigginton, Paolo Antonio Ascierto
70 [GO] 2020―Apr―28 Correction: Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
71 [GO] 2020―Apr―16 Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19 Paolo Antonio Ascierto, Bernard Fox, Walter Urba, Ana Carrizosa Anderson, Michael B Atkins, Ernest C Borden, Julie Brahmer, Lisa H Butterfield, Alessandra Cesano, Daniel Chen, Tanja de Gruijl, Robert O Dillman, Charles G Drake, Leisha A Emens, Thomas F Gajewski, James L Gulley, F Stephen Hodi, Patrick Hwu, David Kaufman, Howard Kaufman, Michael Lotze, Douglas G McNeel, Kim Margolin, Francesco Marincola, Michael J Mastrangelo, Marcela V Maus, David R Parkinson, Pedro J Romero, Paul M Sondel, Stefani Spranger, Mario Sznol, George J Weiner, Jon M Wiggington, Jeffrey S Weber
 [1] 

71 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec